Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Aurobindo Pharma to open second U.S. plant

HYDERABAD, India — Aurobindo Pharma said on Friday it plans to open a second U.S. plant for injectable products.

According to the Hindustan Times, the announcement comes on the heels of President Trump calling on pharmaceutical companies to make more drugs locally. Aurobindo, India’s fourth-biggest drug maker by sales, earns more than half of its revenue in the United States.

“With the current landscape of what’s happening with the U.S. White House administration, and some of the things that may change there, clearly, we don’t think having capacity in the U.S. would be detrimental at this point,” Aurobindo’s U.S. chief, Bob Cunard, told an earnings briefing.

The injectable drugs factory is expected to be at Aurobindo’s New Jersey site.

Trump has proposed a “border tax” on U.S. imports, something that has “worried some” in India’s roughly $15 billion pharmaceutical industry that supplies approximately 30% of the medicines sold in the U.S.

Source: http://www.drugstorenews.com/

0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies